Trials / Withdrawn
WithdrawnNCT04764383
Histaminergic Basis of Fatigue in Multiple Sclerosis
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research study is to identify a way to improve the feeling of exhaustion that patients might experience because of Multiple Sclerosis (MS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | L-Histidine | 1000 mg capsules taken by mouth (PO) twice daily (BID). |
| DRUG | Placebo | Microcrystalline cellulose (placebo) 1000 mg capsules taken by mouth (PO) twice daily (BID). |
| DRUG | Lodosyn | 50 mg capsules taken PO BID. |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2022-10-30
- Completion
- 2022-10-30
- First posted
- 2021-02-21
- Last updated
- 2021-07-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04764383. Inclusion in this directory is not an endorsement.